{"filings":[{"id":94469,"accession_number":"0001213900-26-050998","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K/A","filed_at":"2026-05-01T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Alpha Cognition amends 8-K to add director Sensenig's committee roles, including future Audit Chair","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Director Bethany Sensenig appointed to Audit Committee and Governance & Nomination Committee on April 28, 2026.","Effective after June 16, 2026 annual meeting, Sensenig will become Chair of the Audit Committee.","Amendment No. 1 solely updates committee assignments for previously reported director appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":94471,"accession_number":"0001213900-26-045668","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2026-04-20T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Alpha Cognition appoints Bethany Sensenig to board of directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Bethany Sensenig appointed director on April 15, 2026; previously CFO/Head of Ops at Radius Health.","Sensenig also serves on boards of Supernus Pharmaceuticals (SUPN) and KalVista Pharmaceuticals (KALV).","Received initial grant of 5,489 RSUs and 6,991 stock options (exercise price $6.65), vesting one year from grant.","Sensenig spent 13 years at Biogen in senior finance roles with P&L accountability for over $1B annual revenue.","Compensated per company's non-employee director compensation policy; no arrangements or family relationships."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":94470,"accession_number":"0001213900-26-043517","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2026-04-14T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Alpha Cognition settles Galantos royalty obligations for EUR 5.2M one-time payment, ~40% discount","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Entered settlement agreement with Galantos Pharma to extinguish all future royalty and milestone obligations under the Memogain APA.","One-time payment of EUR 5,214,220, representing approximately 40% discount to estimated present value of remaining obligations.","Galantos is in liquidation; payment fully releases Alpha and related parties from any claims under the original agreement.","Previously paid EUR 785,780 in royalties; the settlement eliminates all future contingent payments for benzgalantamine (ALPHA-1062).","Payment due by April 15, 2026; agreement includes mutual releases, non-disparagement, and confidentiality provisions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":106870,"accession_number":"0001213900-26-035696","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2026-03-27T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Alpha Cognition sets June 16, 2026 annual meeting; record date April 24, 2026","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Annual General Meeting scheduled for June 16, 2026.","Record date for notice and voting is April 24, 2026.","Notice filed with Canadian securities regulators."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":106869,"accession_number":"0001213900-26-034778","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2026-03-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alpha Cognition FY2025 revenue $10.2M, net loss $20.7M; ZUNVEYL bottles up 62% QoQ","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2025 total revenue $10.2M: ZUNVEYL net product revenue $6.8M + licensing $3.4M.","Q4 ZUNVEYL net product revenue $2.5M; 4,941 bottles dispensed (+62% QoQ); December strongest month.","Net loss $20.7M vs $14.8M in 2024; operating loss $22.7M vs $12.0M in 2024.","Cash $66.0M at year-end; expects ~2-year runway after $40M capital raise in Oct 2025.","Executed second national PBM contract, now covering two of four major long-term care PBMs."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":106868,"accession_number":"0001213900-26-019355","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2026-02-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Len Mertz not seeking re-election at 2026 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Len Mertz notified Board on Feb 18, 2026, that he will not stand for re-election.","He will continue serving until the 2026 annual meeting when his term expires.","Departure is not due to any disagreement with the Company on operations, policies, or practices."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":106867,"accession_number":"0001213900-26-004765","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2026-01-15T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Alpha Cognition grants equity awards to CEO, COO, and interim CFO","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Michael McFadden receives 190,549 RSUs vesting 1/3 annually over 3 years, 177,576 stock options with quarterly vesting after first year.","CEO also granted 76,220 performance share units with vesting tied to stock price targets ranging from $12 to $28 per share.","COO Lauren D'Angelo receives 137,195 RSUs (3-year vesting) and 106,545 stock options (first 1/3 at one year, then quarterly).","Interim CFO Henry Du receives 20,579 RSUs and 15,982 stock options with same vesting schedules.","All grants made under the 2025 Stock and Incentive Plan on January 9, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123193,"accession_number":"0001213900-25-098886","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K/A","filed_at":"2025-10-15T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Alpha Cognition replaces auditor Manning Elliott with CBIZ after relocating to Texas","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Manning Elliott resigned on Oct 10, 2025, due to not being licensed in Texas after company moved HQ from Canada.","No disagreements or reportable events existed with Manning Elliott; resignation is administrative only.","Audit Committee approved engagement of CBIZ CPAs P.C. as new independent registered public accounting firm.","This 8-K/A corrects a typographical error in a date from the prior filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123195,"accession_number":"0001213900-25-098739","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2025-10-14T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Alpha Cognition replaces auditor Manning Elliott with CBIZ after HQ move to Texas","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Manning Elliott resigned as auditor on Oct 10, 2025 due to lack of Texas license after company relocated from Canada.","No disagreements or reportable events occurred during Manning Elliott's tenure; its reports were unqualified.","Audit Committee engaged CBIZ CPAs P.C. as successor independent registered public accounting firm on Oct 10, 2025.","Company states the transition is administrative and not related to any accounting or disclosure disputes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123194,"accession_number":"0001213900-25-094911","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2025-10-02T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Alpha Cognition prices $35M oversubscribed public offering at $6.25/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of ~$35M from 5.6M shares (incl. pre-funded warrants) at $6.25 per share.","Offering was oversubscribed; led by premier healthcare-dedicated investor and large existing shareholders.","Expected to close Oct 2, 2025; underwriter has 30-day option to purchase up to 840K additional shares.","Net proceeds to accelerate commercial launch of ZUNVEYL (Benzgalantamine) for Alzheimer's disease.","Company expects total cash position of approximately $70 million following the closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":139862,"accession_number":"0001213900-25-080012","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2025-08-22T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Alpha Cognition enters $75M ATM equity agreement with H.C. Wainwright","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["ATM agreement allows sale of up to US$75M of common shares at market prices.","H.C. Wainwright to serve as sales agent; commission capped at 3.0% of gross proceeds.","Company retains sole discretion to sell shares, suspend offers, or terminate agreement.","Sales will be made on Nasdaq Capital Market or as agreed with agent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157455,"accession_number":"0001213900-25-056752","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2025-06-23T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Alpha Cognition stockholders approve 2025 Stock Incentive Plan, re-elect six directors","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["2025 Stock Incentive Plan approved (3,858,186 for, 444,702 against, 35,288 abstain).","Number of directors set at six; all six nominees re-elected by majority vote.","Ratification of Manning Elliot LLP as independent auditor for FY 2025 approved (8,402,007 for).","Annual meeting held June 19, 2025; quorum present with 8,404,660 shares represented."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157454,"accession_number":"0001213900-25-030683","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2025-04-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Alpha Cognition appoints Robert Wills to Board; John Havens not seeking re-election","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Havens will not stand for re-election at the 2025 annual meeting; no disagreement with company.","Robert Wills appointed to Board and Governance/Nominating Committee effective April 7, 2025.","Wills receives $40,000 annual retainer and $5,000 for committee service per non-employee director policy.","Initial grant of 35,575 stock options at $4.83 per share, vesting 12.5% at grant then quarterly over 24 months.","Wills has >40 years pharma experience; current board roles at Milestone (MIST), Parion, and Oncternal (ONCT)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":175824,"accession_number":"0001213900-25-018138","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Alpha Cognition approves CEO and COO compensation packages totaling $3.5M and $2.3M for FY2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Michael McFadden: $625K base, $375K bonus target, $2.5M stock options ($3.5M total).","COO Lauren D'Angelo: $500K base, $300K bonus target, $1.5M stock options ($2.3M total).","Director compensation raised to 50th percentile of peer group: $40K base ($70K chair) plus option grants.","Compensation reviewed by Global Governance Advisors; prior pay was below 25th percentile of peers.","One-time $100K stock option grants for long-standing non-employee directors as catch-up."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":192736,"accession_number":"0001213900-24-111194","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2024-12-20T23:59:59+00:00","items":["3.02","9.01"],"status":"ready","headline":"Alpha Cognition issues 34,196-share representative purchase warrant at $7.18","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued representative purchase warrant to purchase up to 34,196 shares of common stock.","Exercisable from June 14, 2025 to November 8, 2029; initial exercise price $7.18 per share.","Warrant issued to Titan Partners Group LLC as representative of underwriters."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":192735,"accession_number":"0001213900-24-099596","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2024-11-18T23:59:59+00:00","items":["1.01","3.02","3.03","9.01"],"status":"ready","headline":"Alpha Cognition closes $46.2M public offering of common shares and pre-funded warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Closed underwritten public offering of 8,695,653 common shares and/or pre-funded warrants for net proceeds of ~$46.15 million (or $52.48 million with full underwriter option).","Issued underwriter warrants to purchase 608,696 common shares at $7.18/share, exercisable from May 8, 2025 to Nov 13, 2029.","Convertible notes from September 2024 private placement automatically converted into 801,412 common shares at $5.75 per share.","Issued additional 215,418 warrants to noteholders; exercise price of existing warrants adjusted to $7.19 per share.","Proceeds to fund commercialization of ZUNVEYL, pipeline R&D, CMC activities, and working capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":192734,"accession_number":"0001213900-24-094626","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2024-11-05T23:59:59+00:00","items":["3.03","9.01"],"status":"ready","headline":"Alpha Cognition approves 1:25 reverse stock split effective Nov 5, 2024 to meet Nasdaq minimum bid","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved 1-for-25 reverse split; authorized common shares reduced from ~150.9M to ~6.0M effective Nov 5, 2024.","Reverse split intended to meet Nasdaq Capital Market minimum share price requirement; no shareholder approval was required.","Fractional shares will be rounded to nearest whole share; no change to name or ticker symbol.","CUSIP changed to 02074J501; Computershare acts as transfer agent for certificate exchanges."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":192733,"accession_number":"0001213900-24-090112","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2024-10-24T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Alpha Cognition appoints Henry Du as interim CFO replacing Jay Yoo","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jay Yoo resigned as interim Principal Accounting and Financial Officer effective October 21, 2024.","Henry Du appointed VP of Finance and Accounting and interim CFO effective October 21, 2024.","Du receives $275k base salary, 40% bonus target, and 800,000 stock options vesting quarterly over 12 quarters.","Du brings over 20 years of experience, most recently as SVP at Amplify Surgical."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":192732,"accession_number":"0001213900-24-086624","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2024-10-09T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Alpha Cognition appoints Jay Yoo as interim principal accounting and financial officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jay Yoo appointed interim Principal Accounting and Financial Officer effective October 2, 2024.","Yoo is a CPA with over 20 years of experience; currently a consultant at CFO Vertical, LLC.","Former CFO Don Kalkofen resigned effective October 1, 2024; mutual agreement not to provide part-time transition services.","Yoo has no familial relationships or reportable transactions with the company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":192731,"accession_number":"0001213900-24-085098","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2024-10-03T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Alpha Cognition shareholders approve quorum increase to 33-1/3% for Nasdaq listing at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Quorum for shareholder meetings raised from 5% to 33-1/3% to satisfy Nasdaq Marketplace Rule 5620(c).","Amendment approved by 56,202,871 votes for, 292,733 against at September 27 annual meeting.","All six director nominees elected; Manning Elliott LLP ratified as auditor.","Meeting turnout: 150,855,536 shares (47.62% of outstanding) present, constituting quorum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209177,"accession_number":"0001213900-24-081881","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K/A","filed_at":"2024-09-26T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Alpha Cognition raises $4.545M via senior convertible notes and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued $4,545,000 aggregate principal of senior convertible notes to accredited investors on Sept 24, 2024.","Initial warrants cover 100% of conversion shares; additional warrants for 50% upon qualified offering.","Private placement under Regulation D, Rule 506(b); securities exempt from registration.","This 8-K/A corrects typographical errors in the Securities Purchase Agreement; substance unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209183,"accession_number":"0001213900-24-081586","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2024-09-25T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Alpha Cognition raises $4.545M via senior convertible notes and warrants","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Gross proceeds of $4.545M from sale of senior convertible notes (10% interest, maturity Sept 2026) and warrants.","Initial conversion/exercise price of $0.422 per share; warrants cover 10,770,133 shares with 5-year term.","Proceeds for general corporate purposes and to meet payments under promissory note with Neurodyn Life Sciences Inc.","Benchmark Company acted as sole placement agent; securities sold under Rule 506(b) of Regulation D.","Registration rights agreement requires filing of resale registration statement for conversion/warrant shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209182,"accession_number":"0001213900-24-073262","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2024-08-28T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Alpha Cognition files management circular for AGM; proposes quorum increase for Nasdaq listing","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Annual general meeting set for September 27, 2024; record date August 21, 2024.","Six director nominees proposed: Michael McFadden, Kenneth Cawkell, Rajeev Bakshi, Len Mertz, John Havens, Phillip Mertz.","Seek re-appointment of Manning Elliott LLP as auditor, remuneration to be fixed by board.","Proposal to amend articles to increase quorum from 5% to 33.33% of outstanding shares, required for Nasdaq listing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209181,"accession_number":"0001213900-24-072967","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2024-08-27T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Alpha Cognition CFO Don Kalkofen resigns effective Oct 1, 2024 to pursue other opportunities","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Don Kalkofen resigned effective October 1, 2024 to pursue other opportunities.","Kalkofen will provide part-time consulting from Oct 1, 2024 through Nov 30, 2025 for transition.","Company plans to appoint an interim CFO and then a permanent replacement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209180,"accession_number":"0001213900-24-067814","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2024-08-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alpha Cognition Q2 net loss $2.1M; FDA approves ZUNVEYL for Alzheimer's","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 2024 net loss $2.1M ($0.01/share) vs Q2 2023 net loss $2.8M ($0.03/share).","Cash and equivalents $1.0M at June 30, 2024; no revenue reported.","R&D expenses $0.9M in Q2, down from $1.3M YoY on trial completion.","FDA approved ZUNVEYL (benzgalantamine) for mild-to-moderate Alzheimer's disease.","G&A expenses rose to $1.2M in Q2, including $2.3M shares for services under Spartan Capital agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209179,"accession_number":"0001213900-24-067133","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2024-08-09T23:59:59+00:00","items":["3.03"],"status":"ready","headline":"Alpha Cognition raises shareholder quorum to 33 1/3% from 5% for Nasdaq listing","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved new quorum policy increasing required shares for shareholder meetings from 5% to 33 1/3%.","Policy effective immediately and may only be changed by further board resolution.","Change supports the Company's proposed listing on the Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209178,"accession_number":"0001013762-24-002122","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2024-07-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Alpha Cognition gets FDA approval for ZUNVEYL to treat mild-to-moderate Alzheimer's","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["FDA approved ZUNVEYL (benzgalantamine) for mild-to-moderate Alzheimer's disease; second oral AD therapy approved this decade.","GI adverse events under 2% and no insomnia observed in bioequivalence studies, designed to bypass GI absorption.","Commercial availability planned in pharmacies nationwide starting Q1 2025.","CEO Michael McFadden called approval a major breakthrough; company targets tolerability issues leading to 55% discontinuation rate."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227071,"accession_number":"0001213900-24-052933","cik":1655923,"company_name":"Alpha Cognition Inc.","ticker":"ACOG","form_type":"8-K","filed_at":"2024-06-14T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Alpha Cognition reduces Spartan Capital fee to 1% and waives future rights for upcoming A.G.P. offering","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Spartan Capital fee on planned public offering cut from 2.5% to 1% via Agreement and Waiver dated June 10, 2024.","Spartan waives future rights under Investment Banking Agreement solely for this transaction, effective at closing.","Offering led by Alliance Global Partners/A.G.P. treated as an Alternative Transaction under Section 3(d).","All other terms of the existing Investment Banking Agreement remain in full force and effect."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":128447612.87071551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}